Tandem Diabetes Care, Inc. (LON: 0M0F)

Market Cap	1.87B
Revenue (ttm)	637.43M
Net Income (ttm)	-94.59M
Shares Out	n/a
EPS (ttm)	-1.45
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	377
Average Volume	235
Open	35.30
Previous Close	35.10
Day's Range	35.30 - 35.81
52-Week Range	17.39 - 42.89
Beta	n/a
RSI	49.38
Earnings Date	Feb 26, 2025

About Tandem Diabetes Care

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company’s flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and deliverin...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2006
• Employees: 2,400
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0M0F

Financial Performance

In 2023, Tandem Diabetes Care's revenue was $747.72 million, a decrease of -6.68% compared to the previous year's $801.22 million. Losses were -$222.61 million, 135.3% more than in 2022.

Financial numbers in USD